A brief version of the Subjects' Response to Antipsychotics questionnaire to evaluate treatment effects

I.M. Lako, R. Bruggeman, E.J. Liemburg, E.R. Heuvel, van den, H. Knegtering, C.J. Slooff, D. Wiersma, K. Taxis

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
1 Downloads (Pure)

Abstract

Background. Monitoring patients' experiences with antipsychotics may help to improve medication adherence and outcome. We aimed to develop a shorter version of a comprehensive 74-item self-report questionnaire suitable for routine monitoring of desired and undesired effects of antipsychotics. Methods. Included were patients with psychotic disorders from seven mental health care organizations in The Netherlands, using antipsychotic medication, who completed the Subjects' Response to Antipsychotics (SRA-74). Exploratory factor analysis (EFA) and similarity analysis based on mutual information were used to identify the latent factor structure of the SRA. Items were reduced according to their metric properties and clinical relevance upon consensus by an expert panel, using a Delphi procedure of three rounds. We determined the internal consistency of the shorter version using Cronbach's alpha. Results. SRA data of N = 1478 patients (mean age of 40 years, 31% females) were eligible for analysis. EFA extracted thirteen factors from the SRA-74, including four factors for desired effects (e.g. recovery of psychosis, cognition and social functioning) and nine factors for undesired effects (e.g. weight gain, flattened affect and increased sleep). Based on this solution 12 items were eliminated for statistical reasons. The expert panel eliminated another 28 items with redundant content, resulting in a 34-item version. The SRA-34 includes 10 desired and 24 clinically relevant undesired effects. Both the subscales for desired and undesired effects have a Cronbach's alpha coefficient of 0.82. Conclusions. The SRA-34 can be used to evaluate desired and undesired effects of antipsychotics in routine clinical practice and research. Keywords: Antipsychotic; Side effects; Satisfaction; Self-report; Factor analysis; Psychotic disorders
Original languageEnglish
Pages (from-to)175-180
Number of pages6
JournalSchizophrenia Research
Volume147
Issue number1
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Antipsychotic Agents
Psychotic Disorders
Statistical Factor Analysis
Self Report
Therapeutics
Medication Adherence
Physiologic Monitoring
Netherlands
Cognition
Weight Gain
Surveys and Questionnaires
Consensus
Mental Health
Sleep
Delivery of Health Care
Research

Cite this

Lako, I.M. ; Bruggeman, R. ; Liemburg, E.J. ; Heuvel, van den, E.R. ; Knegtering, H. ; Slooff, C.J. ; Wiersma, D. ; Taxis, K. / A brief version of the Subjects' Response to Antipsychotics questionnaire to evaluate treatment effects. In: Schizophrenia Research. 2013 ; Vol. 147, No. 1. pp. 175-180.
@article{f4fd18209e064e9aba580016dbf735a9,
title = "A brief version of the Subjects' Response to Antipsychotics questionnaire to evaluate treatment effects",
abstract = "Background. Monitoring patients' experiences with antipsychotics may help to improve medication adherence and outcome. We aimed to develop a shorter version of a comprehensive 74-item self-report questionnaire suitable for routine monitoring of desired and undesired effects of antipsychotics. Methods. Included were patients with psychotic disorders from seven mental health care organizations in The Netherlands, using antipsychotic medication, who completed the Subjects' Response to Antipsychotics (SRA-74). Exploratory factor analysis (EFA) and similarity analysis based on mutual information were used to identify the latent factor structure of the SRA. Items were reduced according to their metric properties and clinical relevance upon consensus by an expert panel, using a Delphi procedure of three rounds. We determined the internal consistency of the shorter version using Cronbach's alpha. Results. SRA data of N = 1478 patients (mean age of 40 years, 31{\%} females) were eligible for analysis. EFA extracted thirteen factors from the SRA-74, including four factors for desired effects (e.g. recovery of psychosis, cognition and social functioning) and nine factors for undesired effects (e.g. weight gain, flattened affect and increased sleep). Based on this solution 12 items were eliminated for statistical reasons. The expert panel eliminated another 28 items with redundant content, resulting in a 34-item version. The SRA-34 includes 10 desired and 24 clinically relevant undesired effects. Both the subscales for desired and undesired effects have a Cronbach's alpha coefficient of 0.82. Conclusions. The SRA-34 can be used to evaluate desired and undesired effects of antipsychotics in routine clinical practice and research. Keywords: Antipsychotic; Side effects; Satisfaction; Self-report; Factor analysis; Psychotic disorders",
author = "I.M. Lako and R. Bruggeman and E.J. Liemburg and {Heuvel, van den}, E.R. and H. Knegtering and C.J. Slooff and D. Wiersma and K. Taxis",
year = "2013",
doi = "10.1016/j.schres.2013.02.027",
language = "English",
volume = "147",
pages = "175--180",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1",

}

Lako, IM, Bruggeman, R, Liemburg, EJ, Heuvel, van den, ER, Knegtering, H, Slooff, CJ, Wiersma, D & Taxis, K 2013, 'A brief version of the Subjects' Response to Antipsychotics questionnaire to evaluate treatment effects', Schizophrenia Research, vol. 147, no. 1, pp. 175-180. https://doi.org/10.1016/j.schres.2013.02.027

A brief version of the Subjects' Response to Antipsychotics questionnaire to evaluate treatment effects. / Lako, I.M.; Bruggeman, R.; Liemburg, E.J.; Heuvel, van den, E.R.; Knegtering, H.; Slooff, C.J.; Wiersma, D.; Taxis, K.

In: Schizophrenia Research, Vol. 147, No. 1, 2013, p. 175-180.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A brief version of the Subjects' Response to Antipsychotics questionnaire to evaluate treatment effects

AU - Lako, I.M.

AU - Bruggeman, R.

AU - Liemburg, E.J.

AU - Heuvel, van den, E.R.

AU - Knegtering, H.

AU - Slooff, C.J.

AU - Wiersma, D.

AU - Taxis, K.

PY - 2013

Y1 - 2013

N2 - Background. Monitoring patients' experiences with antipsychotics may help to improve medication adherence and outcome. We aimed to develop a shorter version of a comprehensive 74-item self-report questionnaire suitable for routine monitoring of desired and undesired effects of antipsychotics. Methods. Included were patients with psychotic disorders from seven mental health care organizations in The Netherlands, using antipsychotic medication, who completed the Subjects' Response to Antipsychotics (SRA-74). Exploratory factor analysis (EFA) and similarity analysis based on mutual information were used to identify the latent factor structure of the SRA. Items were reduced according to their metric properties and clinical relevance upon consensus by an expert panel, using a Delphi procedure of three rounds. We determined the internal consistency of the shorter version using Cronbach's alpha. Results. SRA data of N = 1478 patients (mean age of 40 years, 31% females) were eligible for analysis. EFA extracted thirteen factors from the SRA-74, including four factors for desired effects (e.g. recovery of psychosis, cognition and social functioning) and nine factors for undesired effects (e.g. weight gain, flattened affect and increased sleep). Based on this solution 12 items were eliminated for statistical reasons. The expert panel eliminated another 28 items with redundant content, resulting in a 34-item version. The SRA-34 includes 10 desired and 24 clinically relevant undesired effects. Both the subscales for desired and undesired effects have a Cronbach's alpha coefficient of 0.82. Conclusions. The SRA-34 can be used to evaluate desired and undesired effects of antipsychotics in routine clinical practice and research. Keywords: Antipsychotic; Side effects; Satisfaction; Self-report; Factor analysis; Psychotic disorders

AB - Background. Monitoring patients' experiences with antipsychotics may help to improve medication adherence and outcome. We aimed to develop a shorter version of a comprehensive 74-item self-report questionnaire suitable for routine monitoring of desired and undesired effects of antipsychotics. Methods. Included were patients with psychotic disorders from seven mental health care organizations in The Netherlands, using antipsychotic medication, who completed the Subjects' Response to Antipsychotics (SRA-74). Exploratory factor analysis (EFA) and similarity analysis based on mutual information were used to identify the latent factor structure of the SRA. Items were reduced according to their metric properties and clinical relevance upon consensus by an expert panel, using a Delphi procedure of three rounds. We determined the internal consistency of the shorter version using Cronbach's alpha. Results. SRA data of N = 1478 patients (mean age of 40 years, 31% females) were eligible for analysis. EFA extracted thirteen factors from the SRA-74, including four factors for desired effects (e.g. recovery of psychosis, cognition and social functioning) and nine factors for undesired effects (e.g. weight gain, flattened affect and increased sleep). Based on this solution 12 items were eliminated for statistical reasons. The expert panel eliminated another 28 items with redundant content, resulting in a 34-item version. The SRA-34 includes 10 desired and 24 clinically relevant undesired effects. Both the subscales for desired and undesired effects have a Cronbach's alpha coefficient of 0.82. Conclusions. The SRA-34 can be used to evaluate desired and undesired effects of antipsychotics in routine clinical practice and research. Keywords: Antipsychotic; Side effects; Satisfaction; Self-report; Factor analysis; Psychotic disorders

U2 - 10.1016/j.schres.2013.02.027

DO - 10.1016/j.schres.2013.02.027

M3 - Article

C2 - 23561295

VL - 147

SP - 175

EP - 180

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1

ER -